Finn Somnier

1.6k total citations
28 papers, 1.2k citations indexed

About

Finn Somnier is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Finn Somnier has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Infectious Diseases. Recurrent topics in Finn Somnier's work include Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (12 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Finn Somnier is often cited by papers focused on Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (12 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Finn Somnier collaborates with scholars based in Denmark, Norway and United States. Finn Somnier's co-authors include Inge Kemp Genefke, Olaf B. Paulson, Niels Keiding, Per Soelberg Sørensen, Merete Appleyard, Gudrun Boysen, Gorm Boje Jensen, J Nyboe, Peter Schnohr and J. Boas and has published in prestigious journals such as Neurology, Stroke and The British Journal of Psychiatry.

In The Last Decade

Finn Somnier

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finn Somnier Denmark 17 684 167 151 139 126 28 1.2k
Fatemeh Dehghani Firouzabadi Iran 13 194 0.3× 61 0.4× 109 0.7× 56 0.4× 54 0.4× 51 726
Hussein Algahtani Saudi Arabia 17 354 0.5× 62 0.4× 166 1.1× 91 0.7× 28 0.2× 130 1.2k
P.A. van Doorn Netherlands 18 641 0.9× 80 0.5× 58 0.4× 220 1.6× 32 0.3× 25 1.8k
Adrian I. Espiritu Philippines 16 410 0.6× 68 0.4× 176 1.2× 164 1.2× 43 0.3× 98 936
Jonathan D. Santoro United States 17 247 0.4× 73 0.4× 105 0.7× 119 0.9× 44 0.3× 88 833
Waseem Ahmed United States 13 295 0.4× 51 0.3× 57 0.4× 140 1.0× 15 0.1× 77 932
Lílian Tereza Lavras Costallat Brazil 23 179 0.3× 30 0.2× 44 0.3× 129 0.9× 38 0.3× 67 1.3k
Eun Ja Lee South Korea 17 182 0.3× 26 0.2× 66 0.4× 148 1.1× 62 0.5× 66 1000
Robert V. Groover United States 14 472 0.7× 24 0.1× 47 0.3× 219 1.6× 36 0.3× 24 1.2k
Jorge García‐García Spain 13 246 0.4× 79 0.5× 132 0.9× 140 1.0× 81 0.6× 65 744

Countries citing papers authored by Finn Somnier

Since Specialization
Citations

This map shows the geographic impact of Finn Somnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn Somnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn Somnier more than expected).

Fields of papers citing papers by Finn Somnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn Somnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn Somnier. The network helps show where Finn Somnier may publish in the future.

Co-authorship network of co-authors of Finn Somnier

This figure shows the co-authorship network connecting the top 25 collaborators of Finn Somnier. A scholar is included among the top collaborators of Finn Somnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn Somnier. Finn Somnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stengaard‐Pedersen, K., Magnus Christian Lydolph, Finn Somnier, & Peter Junker. (2016). [Myopathy in a patient during simvastatin and fluconazole treatment].. PubMed. 178(39). 1 indexed citations
2.
Somnier, Finn, et al.. (2016). Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report. Case Reports in Neurology. 8(1). 16–19. 4 indexed citations
3.
Somnier, Finn, et al.. (2015). Mortality in myasthenia gravis: A nationwide population–based follow‐up study in Denmark. Muscle & Nerve. 53(1). 73–77. 47 indexed citations
4.
Trier, Nicole Hartwig, Per Brinch Hansen, Christian A. Vedeler, Finn Somnier, & Gunnar Houen. (2012). Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases/small cell lung cancer. Journal of Neuroimmunology. 243(1-2). 25–33. 29 indexed citations
5.
Brimberg, Lior, Itai Benhar, Kathy Alvarez, et al.. (2012). Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders. Neuropsychopharmacology. 37(9). 2076–2087. 145 indexed citations
6.
Somnier, Finn. (2009). Exacerbation of myasthenia gravis after removal of thymomas. Acta Neurologica Scandinavica. 90(1). 56–66. 6 indexed citations
7.
Somnier, Finn, Wladimir Szpirt, Helge Kjersem, Steen Gammeltoft, & Gudrun Boysen. (2009). RAPID IMPROVEMENT OF MYASTENIA GRAVIS WITH A NEW TECHNIQUE OF PLASMA EXCHANGE:. Acta Neurologica Scandinavica. 65(S90). 132–133.
8.
Somnier, Finn. (2005). Increasing incidence of late-onset anti–AChR antibody–seropositive myasthenia gravis. Neurology. 65(6). 928–930. 92 indexed citations
9.
Somnier, Finn & Peter J. Engel. (2002). The occurrence of anti-titin antibodies and thymomas. Neurology. 59(1). 92–98. 40 indexed citations
10.
Somnier, Finn, Geir Skeie, Johan A. Aarli, & W. Trojaborg. (1999). EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. European Journal of Neurology. 6(5). 555–563. 37 indexed citations
11.
Somnier, Finn. (1996). Myasthenia gravis.. PubMed. 43(1). 1–10. 5 indexed citations
12.
Somnier, Finn. (1994). Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: The use of cell line TE671 as a source of AChR antigen. Journal of Neuroimmunology. 51(1). 63–68. 16 indexed citations
13.
Somnier, Finn. (1993). Clinical implementation of anti-acetylcholine receptor antibodies.. Journal of Neurology Neurosurgery & Psychiatry. 56(5). 496–504. 57 indexed citations
14.
Somnier, Finn & W. Trojaborg. (1993). Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 89(2). 73–87. 29 indexed citations
15.
Somnier, Finn, Niels Keiding, & Olaf B. Paulson. (1991). Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population Survey. Archives of Neurology. 48(7). 733–739. 108 indexed citations
16.
Somnier, Finn, Mikkel Østergaard, Gudrun Boysen, Peter Bruhn, & B. Mikkelsen. (1990). Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. Psychopharmacology. 101(1). 43–46. 4 indexed citations
17.
Somnier, Finn, et al.. (1989). Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies. Journal of Neuroimmunology. 22(2). 123–127. 16 indexed citations
18.
Boysen, Gudrun, J Nyboe, Merete Appleyard, et al.. (1988). Stroke incidence and risk factors for stroke in Copenhagen, Denmark.. Stroke. 19(11). 1345–1353. 220 indexed citations
19.
Rødgaard, Anne, Finn Cilius Nielsen, R. Djurup, Finn Somnier, & Steen Gammeltoft. (1987). Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.. PubMed. 67(1). 82–8. 117 indexed citations
20.
Melgaard, B & Finn Somnier. (1981). Cardiac neuropathy in chronic alcoholics. Clinical Neurology and Neurosurgery. 83(4). 219–224. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatemeh Dehghani Firouzabadi Breakdown of academic impact, for papers by Hussein Algahtani Breakdown of academic impact, for papers by P.A. van Doorn Breakdown of academic impact, for papers by Adrian I. Espiritu Breakdown of academic impact, for papers by Jonathan D. Santoro Breakdown of academic impact, for papers by Waseem Ahmed Breakdown of academic impact, for papers by Lílian Tereza Lavras Costallat Breakdown of academic impact, for papers by Eun Ja Lee Breakdown of academic impact, for papers by Robert V. Groover Breakdown of academic impact, for papers by Jorge García‐García
Rankless by CCL
2026